AMPK-Mediated Autophagy Induction By Bisdemethoxycurcumin Attenuates Senescence And Amyloid Pathology In 3Xtg-AD Mice
Alzheimer’s disease is a devastating condition characterized by memory loss and cognitive decline, and research suggests that two key cellular processes, cellular aging (senescence) and a “self-cleaning” mechanism called autophagy, play a significant role in its progression. In the brains of individuals with Alzheimer’s, there’s often an increase in senescent cells and a decrease in autophagy, which is essential for removing damaged cellular components and toxic proteins.
Recent findings highlight the potential of a natural compound, bisdemethoxycurcumin (BDMC), found in turmeric, to address these issues. This compound was found to stimulate autophagy in brain support cells called astrocytes. Importantly, this activation of autophagy by BDMC helped reverse the signs of cellular aging in these astrocytes. The mechanism behind this beneficial effect involves a crucial energy-sensing protein known as AMPK, which acts as a master regulator of cellular metabolism and is vital for initiating autophagy.
Beyond its effects on cellular aging, BDMC also demonstrated the ability to help clear amyloid-beta, a protein that accumulates and forms harmful plaques in the brains of Alzheimer’s patients. To further investigate these promising results, the compound was tested in a mouse model of Alzheimer’s disease. The study confirmed that BDMC could successfully cross the blood-brain barrier, reaching the brain where it significantly reduced markers of cellular aging and the amyloid-beta burden. These positive molecular changes ultimately translated into improved working memory and better physical coordination in the treated mice.
These findings suggest that this natural compound warrants further investigation as a potential therapeutic strategy for managing Alzheimer’s disease by targeting both cellular aging and the accumulation of harmful proteins.
Source: link to paper